A neurological condition that causes impairments in movement; notably tremor, rigidity and slowing of actions. Sometimes shortened to PD, it is caused by the loss of specific neurons in the movement pathways within the brain. In addition to movement impairments, people are commonly affected by non-motor symptoms such as cognitive impairment, sleep disruption, and mood and anxiety issues, to name a few.
Parkinson’s disease is a condition of the brain that causes a resting tremor which is typically worse in one side compared to the other. It is a neurodegenerative disease for which there is no cure and typically increases in severity with time. Currently available medications which target dopaminergic pathways (a pathway in the brain where the predominant signalling molecule is dopamine) have been a success for Parkinson’s disease treatment. However, some patients are affected by treatment-resistant motor symptoms, treatment induced movement disorders, and non-motor symptoms for which there are limited therapeutic options.
Parkinson’s disease is most common in adult males over the age of 50 and globally the number of individuals with Parkinson’s disease is estimated to double between 2005 to 2030 (source: Dorsey EA, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007 Jan 30;68(5):384-6.)
The exact cause of Parkinson’s is unknown but the disease is defined by a loss of dopaminergic (or dopamine containing) nerve cells in the substantia nigra part of the brain. The substantia nigra is a part of a group of structures called the basal ganglia, which play an essential role in the co-ordination of movement.
In addition, people with Parkinson’s disease also contain abnormal build-up of protein in structures called Lewy bodies.
Whilst it is more common in people over the age of 50, there are cases of people under 50 being diagnosed with Parkinson’s disease.
Genetics can play a role in developing the disease, however direct genetic inheritance of Parkinson’s disease from a parent is rare.
Parkinson’s symptoms may start off mild and often begin with resting tremors of the hands. Typically symptoms are worse on one side compared to the other. Additional Parkinson’s disease symptoms may follow later including:
Parkinson’s disease diagnosis is given based upon symptoms, medical history, and full physical examination carried out by a healthcare professional; there isn’t a test for the disease. It can be hard to diagnose at the onset as early signs of Parkinson’s disease are normally very mild.
For those with atypical features of Parkinson’s Plus syndromes MRI brain and functional neuroimaging may be performed.
There is not a cure for Parkinson’s disease, but there are treatment options to reduce symptoms and slow progression. Parkinson’s treatments include:
Research into the effect of medicinal cannabis on Parkinson’s disease is limited. However, following the legalisation of cannabis for medical purposes in 2018, there has been a rise in people looking towards medical cannabis. When first-line therapies have not proved effective at reducing symptoms, medical cannabis may be considered an option for Parkinson’s disease.
For further information and to find out more about medical cannabis, click here to discover more about our award-winning Sapphire Access Scheme. Alternatively, complete an eligibility assessment now. Once complete, one of our clinicians will review your application and advise whether you are eligible for progression to an appointment.
Males over the age of 50 are most commonly diagnosed with Parkinson’s disease, however, cases have been diagnosed in people under this age. Men are more likely to develop Parkinson’s with cases in men being 45% more common than cases in women (source Parkinsons.org).
The main symptoms of Parkinson’s disease are:
Parkinsonism in an umbrella term for different conditions which cause the core features which are also seen in Parkinson’s disease. Parkinson’s disease, specifically, is caused by the loss of specific nerve fibres containing dopamine and an abnormal build-up of protein in structures called Lewy bodies. The other causes of parkinsonism include but are not necessarily limited to:
There is no test that can detect Parkinson’s disease. Healthcare professionals will review an individual’s medial history and symptoms as well as a performing a full physical examination to determine whether their patient has developed Parkinson’s.
Treatment options vary from person to person and will depend on the type of Parkinsonism. Physical therapy, prescription medication, and surgery can all be considered when looking at treatment options for Parkinson’s disease.
If you are a patient or carer seeking an appointment to discuss treatment with medical cannabis, you can complete this form and we can assist you with this.
Eligible patients can provide us with their healthcare records or we can obtain these through your GP. This is to confirm that a patient’s condition has been fully assessed and all other treatment options have been attempted. We will ensure that the primary care provider receives all treatment communication to maintain the highest level of clinical governance.
We also accept referrals from healthcare professionals.
To refer a patient to us, please click here to fill and securely submit a referral form.